Antiretroviral Therapy, Highly Active
"Antiretroviral Therapy, Highly Active" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.
| Descriptor ID |
D023241
|
| MeSH Number(s) |
E02.319.310.075
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antiretroviral Therapy, Highly Active".
Below are MeSH descriptors whose meaning is more specific than "Antiretroviral Therapy, Highly Active".
This graph shows the total number of publications written about "Antiretroviral Therapy, Highly Active" by people in this website by year, and whether "Antiretroviral Therapy, Highly Active" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 2 | 1 | 3 |
| 2001 | 3 | 1 | 4 |
| 2002 | 4 | 3 | 7 |
| 2003 | 0 | 6 | 6 |
| 2004 | 6 | 1 | 7 |
| 2005 | 1 | 3 | 4 |
| 2006 | 3 | 3 | 6 |
| 2007 | 3 | 0 | 3 |
| 2008 | 6 | 3 | 9 |
| 2009 | 4 | 5 | 9 |
| 2010 | 2 | 9 | 11 |
| 2011 | 4 | 7 | 11 |
| 2012 | 3 | 5 | 8 |
| 2013 | 2 | 1 | 3 |
| 2014 | 4 | 6 | 10 |
| 2015 | 2 | 1 | 3 |
| 2016 | 0 | 2 | 2 |
| 2017 | 3 | 2 | 5 |
| 2018 | 1 | 2 | 3 |
| 2019 | 0 | 5 | 5 |
| 2020 | 2 | 3 | 5 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiretroviral Therapy, Highly Active" by people in Profiles.
-
HIV and Aging in the Era of ART and COVID-19: Symposium Overview. J Acquir Immune Defic Syndr. 2022 02 01; 89(Suppl 1):S3-S9.
-
Mitochondrial Functions Are Compromised in CD4 T Cells From ART-Controlled PLHIV. Front Immunol. 2021; 12:658420.
-
Nursing Science Throughout the Epidemic: Lessons Learned and the Way Forward. J Assoc Nurses AIDS Care. 2021 May-Jun 01; 32(3):223-224.
-
The Lived Experience of Antiretroviral Therapy for Pregnant Women: Antiretroviral Therapy Adherence as a Balancing Act. J Assoc Nurses AIDS Care. 2020 Jul-Aug; 31(4):448-456.
-
Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events. AIDS. 2020 05 01; 34(6):849-857.
-
The far-reaching HAND of cART: cART effects on astrocytes. J Neuroimmune Pharmacol. 2021 03; 16(1):144-158.
-
Sialylation and fucosylation modulate inflammasome-activating eIF2 Signaling and microbial translocation during HIV infection. Mucosal Immunol. 2020 09; 13(5):753-766.
-
Implementing Rapid Initiation of Antiretroviral Therapy for Acute HIV Infection Within a Routine Testing and Linkage to Care Program in Chicago. J Int Assoc Provid AIDS Care. 2020 Jan-Dec; 19:2325958220939754.
-
Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy. AIDS. 2019 12 01; 33(15):2289-2298.
-
A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection. Clin Infect Dis. 2019 09 13; 69(7):1165-1172.